News
- OPEN BRIEFING - BNO CEO ON BNC210 CLINICAL TRIALS
191 kb
02-Sep-2010 BNC210 DATA PRESENTED AT LEADING EUROPEAN FORUM 30-Aug-2010
- 2010 STATUTORY ACCOUNTS 6976 kb
19-Aug-2010 - BIONOMICS NOW JULY NEWSLETTER 2010 kb
13-Jul-2010 - ANTI-ANXIETY COMPOUND BNC210 PHASE I TRIAL SUCCESSFUL: ESTABLISHES FOUR-FOLD INCREASE IN BLOOD DRUG LEVELS FOLLOWING FOOD INTAKE 69 kb
21-Jun-2010 BIONOMICS PRESENTS BNC105 CLINICAL DATA AT ASCO 07-Jun-2010
- OPEN BRIEFING - CEO ON MERCK SERONO EXTENSION 223 kb
25-May-2010 MERCK SERONO EXTENDS RESEARCH TERM AND FUNDING FOR MULTIPLE SCLEROSIS PROJECT WITH BIONOMICS 24-May-2010
- BIONOMICS LIMITED BROADCAST 31 kb
13-May-2010 SECOND BNC210 PHASE I CLINICAL TRIAL COMMENCES 06-May-2010
NEW BNC105 DATA PRESENTED AT PREMIER INTERNATIONAL CANCER CONFERENCE 16-Apr-2010
- OPEN BRIEFING - CEO ON CLINICAL TRIALS UPDATE 191 kb
31-Mar-2010 BNC105 PHASE II MESOTHELIOMA CLINICAL TRIAL STARTS 26-Mar-2010
- BIONOMICS NOW NEWSLETTER - MARCH 2010 1063 kb
16-Mar-2010 - BNC210 CLINICAL TRIAL RESULTS CONFIRM SAFETY AND INDICATE REDUCED STRESS HORMONE LEVELS 49 kb
02-Mar-2010 - HALF YEARLY REPORT AND ACCOUNTS 1397 kb
18-Feb-2010 - US INVESTOR PRESENTATION 1640 kb
09-Feb-2010 BIONOMICS LIMITED BROADCAST 04-Feb-2010
- POSITIVE NEW BNC210 DATA 914 kb
02-Feb-2010 BNC105 US RENAL CANCER TRIAL INITIATED 27-Jan-2010
- OPEN BRIEFING - BNC105 PHASE II TRIAL FOR MESOTHELIOMA 210 kb
22-Dec-2009 APPOINTMENT OF CHIEF FINANCIAL OFFICER AND COMPANY SECRETARY 18-Dec-2009
- BNO NOW DECEMBER 09 NEWSLETTER 329 kb
14-Dec-2009 - BIONOMICS 2009 AGM BROADCAST 31 kb
06-Nov-2009 - CHAIRMAN'S ADDRESS 28 kb
04-Nov-2009 - CEO'S ADDRESS 279 kb
04-Nov-2009 - NEW CHAIRMAN'S ADDRESS 29 kb
04-Nov-2009 FIRST STAGE OF BNC210 CLINICAL TRIAL SUCCESSFULLY COMPLETED 27-Oct-2009
- LATEST BNC210 DATA TO BE PRESENTED IN US 175 kb
16-Oct-2009 - RESULTS OF MEETING 73 kb
09-Oct-2009 SPP CLOSES OVERSUBSCRIBED 08-Oct-2009
INVITATION TO SHAREHOLDERS TO TOUR BIONOMICS FACILITY 08-Oct-2009
- NOTICE OF ANNUAL GENERAL MEETING /PROXY FORM 328 kb
02-Oct-2009 - ANNUAL REPORT TO SHAREHOLDERS 2009 1206 kb
30-Sep-2009 - BOARDROOM RADIO BROADCAST - BNO INVESTOR UPDATE SEPTEMBER 2009 30 kb
18-Sep-2009 - CEO OPEN BRIEFING 59 kb
17-Sep-2009 - 2009 SHARE PURCHASE PLAN OFFER - ADDENDUM 692 kb
17-Sep-2009 CAPITAL RAISING UPDATE - SHARE PURCHASE PLAN 11-Sep-2009
- NOTICE OF EXTRAORDINARY GENERAL MEETING & PROXY FORM 926 kb
10-Sep-2009 - $15 MILLION CAPITAL RAISING 36 kb
08-Sep-2009 - INVESTOR UPDATE - SEPTEMBER 2009 1350 kb
08-Sep-2009 START-UP PLACEMENT 03-Sep-2009
- APPENDIX 4E 76 kb
28-Aug-2009 - BNO JULY 2009 NEWSLETTER 433 kb
27-Jul-2009 BIONOMICS TO UNDERTAKE US CLINICAL TRIAL OF BNC105 IN RENAL CELL CANCER 02-Jul-2009
- OPEN BRIEFING - BNO CEO ON MILESTONES ACHIEVED 63 kb
02-Jul-2009 - BNO BROADCAST – HEALTHY INVESTMENT eCONFERENCE PRESENTATION 32 kb
01-Jul-2009 PHASE I CLINICAL TRIAL OF BIONOMICS’ ANTI ANXIETY DRUG BNC210 INITIATED 25-Jun-2009
CANCER FIGHTING COMPOUND - BNC105 TO AIR ON ABC RADIO AUSTRALIA 15-Jun-2009
- BOARDROOM RADIO BROADCAST - BNC210 APPROVED TO ENTER TRIAL 32 kb
04-Jun-2009 INITIAL DATA FROM BNC105 PHASE I CLINICAL TRIAL PRESENTED 29-May-2009
- OEN BRIEFING BNC105 INTERIM DATA 59 kb
29-May-2009 BIONOMICS’ ANXIETY DRUG CANDIDATE APPROVED TO ENTER HUMAN CLINICAL TRIAL 21-May-2009
- BNO - CEO PRESENTATION MAY 2009 1675 kb
05-May-2009 NEW BNC105 DATA PRESENTED AT THE AMERICAN ASSOCIATION FOR CANCER RESEARCH (AACR) CONFERENCE 22-Apr-2009
- OPEN BRIEFING - NEW DATA ON BNC105 58 kb
22-Apr-2009 - BIONOMICS NAMED IN SMART 100 INDEX 28 kb
15-Apr-2009 - BIONOMICS APRIL 2009 NEWSLETTER 304 kb
09-Apr-2009 - BOARDROOM RADIO BROADCAST - HALF YEARLY REPORT 31 kb
03-Mar-2009 KEY INSTITUTIONAL INVESTOR SUPPORTS BNO CAPITAL RAISING 10-Feb-2009
- OPEN BRIEFING - CEO ON OPTION EXPIRY 51 kb
05-Feb-2009 BNOOB OPTIONS EXERCISE 30-Jan-2009
- INVESTOR PRESENTATION - JANUARY 2009 1683 kb
19-Jan-2009 - OPEN BRIEFING - CEO UPDATE 62 kb
15-Jan-2009 - BIONOMICS NOW JANUARY NEWSLETTER 376 kb
14-Jan-2009 BIONOMICS ANNOUNCES ADDITION TO BOARD 23-Dec-2008
- BNOOB OPTIONS REMINDER 51 kb
22-Dec-2008 BIONOMICS’ ANTI-ANXIETY CANDIDATE BNC210 SUCCESSFULLY COMPLETES SAFETY STUDIES 17-Dec-2008
OPTIONS UNDERWRITING 16-Dec-2008
- OPEN BRIEFING - BNO CEO ON RECENT DEVELOPMENTS 58 kb
12-Nov-2008 AGM BROADCAST 11-Nov-2008
AUSTIN HEALTH COMES ON BOARD BNC105 TRIAL 05-Nov-2008
- BNC105 CLINICAL TRIAL UPDATE 55 kb
16-Sep-2008 - US AND EUROPEAN INVESTOR PRESENTATION 670 kb
08-Sep-2008 - BIONOMICS NOW SEPTEMBER NEWSLETTER 283 kb
05-Sep-2008 - BIONOMICS’ COMPOUND BNC210 DECREASES ANXIETY IN ANIMAL MODELS - LATEST DATA PRESENTED AT EUROPEAN CONFERENCE 55 kb
01-Sep-2008 - BIONOMICS' 2007/2008 PRELIMINARY FINAL RESULTS 68 kb
22-Aug-2008 BIONOMICS EXTENDS CONTRACT OF CEO AND MANAGING DIRECTOR DEBORAH RATHJEN 08-Aug-2008
- BNO AUDIO BROADCAST 31 kb
17-Jul-2008 BIONOMICS COMPLETES GMP SYNTHESIS OF ANTI-ANXIETY DRUG BNC210 09-Jul-2008
- BNO NEWSLETTER JULY 2008 276 kb
30-Jun-2008 - OPEN BRIEFING - BNO & MERCK SERONO DEVELOPMENT AGREEMENT 58 kb
24-Jun-2008 MERCK SERONO AND BIONOMICS ANNOUNCE MULTIPLE SCLEROSIS DEVELOPMENT AND LICENSING AGREEMENT 19-Jun-2008
BIONOMICS AWARDS GMP MANUFACTURE CONTRACT FOR ANXIETY DRUG CANDIDATE BNC210 16-Apr-2008
BIONOMICS PRESENTS BNC105 DATA AT INTERNATIONAL CANCER CONFERENCE 14-Apr-2008
- BNO NEWSLETTER APRIL 2008 319 kb
02-Apr-2008 BIONOMICS ADVANCES ANTI-ANXIETY CANDIDATE BNC210 11-Mar-2008
BIONOMICS STRENGTHENS BOARD WITH NEW APPOINTMENT 28-Feb-2008
- CEO ON BNC105 PHASE I CLINICAL TRIALS 58 kb
27-Feb-2008 TREATMENT OF FIRST PATIENT IN PHASE I CLINICAL TRIAL OF BIONOMICS’ ANTI-CANCER DRUG BNC105 26-Feb-2008
BIONOMICS ACHIEVES US$1 MILLION MILESTONE PAYMENT FROM GENMAB 19-Feb-2008
- BIONOMICS NOW NEWSLETTER 304 kb
21-Jan-2008 BIONOMICS’ ANTI-CANCER COMPOUND GAINS IND APPROVAL 22-Nov-2007
- CHAIRMAN AND CEO ADDRESS 875 kb
07-Nov-2007 BIONOMICS ACHIEVES KEY MILESTONES 07-Nov-2007
- OPEN BRIEFING - CEO ON PIPELINE DEVELOPMENT STATUS 67 kb
07-Nov-2007 AGM BROADCAST 07-Nov-2007
- LATEST DATA PRESENTED AT INTERNATIONAL CONFERENCE 309 kb
05-Oct-2007 - NEWSLETTER TO SHAREHOLDERS 185 kb
14-Sep-2007 2006 / 2007 FINANCIAL RESULTS – VARIATION TO 4E 07-Sep-2007
BIONOMICS' 2006/2007 PRELIMINARY FINAL RESULTS 29-Aug-2007
BIONOMICS TO DEVELOP CANCER DRUG TARGET BNO69 WITH SUPPORT FROM THE CANCER THERAPEUTICS CRC 06-Aug-2007
- IBRO 2007 CONFERENCE POSTER - BNC210 369 kb
13-Jul-2007 - IBRO 2007 CONFERENCE POSTER - Kv1.3 ION CHANNEL BLOCKERS 212 kb
13-Jul-2007 BIONOMICS PRESENTS MULTIPLE SCLEROSIS AND ANXIETY DRUG DATA AT INTERNATIONAL CONFERENCE 13-Jul-2007
- s708A PLACEMENT NOTICE 51 kb
05-Jul-2007 - BNOOA OPTION EXPIRY NOTICE 25 kb
03-Jul-2007 AUDIO BROADCAST - BIONOMICS RAISES $10 MILLION IN PRIVATE PLACEMENT 21-Jun-2007
BIONOMICS RAISES $10 MILLION IN PRIVATE PLACEMENT 20-Jun-2007
- BIONOMICS NEWSLETTER - JUNE 2007 204 kb
12-Jun-2007 BIONOMICS’ VALIDATES THIRD CANCER APPLICATION FOR ANTI-CANCER COMPOUND BNC105 04-Jun-2007
- OPEN BRIEFING - BIONOMICS PIPELINE UPDATE 64 kb
04-Jun-2007 AUDIO BROADCAST - BIONOMICS MD - NEW DRUG CANDIDATE FOR ANXIETY 31-May-2007
BIONOMICS VALIDATES DRUG CANDIDATE FOR ANXIETY 29-May-2007
BIONOMICS COMPLETES GMP SYNTHESIS OF CANCER DRUG BNC105 ON TIME AND ON BUDGET 23-Apr-2007
- OPEN BRIEFING - UPDATE ON BNC105 MILESTONES 59 kb
23-Apr-2007 US$890 MILLION VDA DEAL INDICATES VALUE OF BIONOMICS’ BNC105 CANCER COMPOUND 23-Apr-2007
BIONOMICS ESTABLISHES NEW LABORATORY FACILITY TO ACCELERATE LATER STAGE DRUG DEVELOPMENT 19-Apr-2007
BIONOMICS PRESENTS CANCER DATA AT AACR CONFERENCE 17-Apr-2007
- AACR Poster 1406 kb
17-Apr-2007 - INVESTOR BRIEFING - EXCELLENCE IN BIOTECHNOLOGY & INVESTMENT CONFERENCE, SYDNEY 1193 kb
20-Mar-2007 - M & A PRESENTATION – EXCELLENCE IN BIOTECHNOLOGY & INVESTMENT CONFERENCE, SYDNEY 136 kb
20-Mar-2007 - BIONOMICS SHAREHOLDER NEWSLETTER – MARCH 2007 259 kb
13-Mar-2007 BIONOMICS TAKES KEY STEP FORWARD IN THE DEVELOPMENT OF ANTI-CANCER DRUG BNC105 21-Feb-2007
BIONOMICS MEETS WITH FDA IN US 17-Jan-2007
BIONOMICS TO BENEFIT FROM AU$37.60M FEDERAL CRC GRANT FOR CANCER DRUG DEVELOPMENT 02-Jan-2007
BIONOMICS NEWSLETTER 04-Dec-2006
- BIONOMICS MD UPDATES OUTLOOK 34 kb
16-Nov-2006 - BIONOMICS DELIVERS ON MILESTONES FOR DRUG DISCOVERY PROGRAMS 32 kb
09-Nov-2006 - AGM CHAIRMAN AND CEO ADDRESSES 2006 554 kb
09-Nov-2006 BNO AUDIO BROADCAST 09-Nov-2006
BNO AUDIO BROADCAST 25-Oct-2006
BIONOMICS AND SAFC PHARMA SIGN CONTRACT TO MANUFACTURE BNC105 25-Oct-2006
- ASIA PACIFIC LIFE SCIENCES FORUM - PRESENTATION 1468 kb
12-Oct-2006 BIONOMICS ANTI CANCER PAPER SELECTED AS 'LATE BREAKING NEWS' AT UK CANCER CONFERENCE 11-Oct-2006
- BIONOMICS RAISES $5 MILLION THROUGH PRIVATE PLACEMENT 24 kb
21-Sep-2006 Director Appointment 18-Sep-2006
BIONOMICS COLLABORATOR PRESENTS ADVANCES TOWARD NEW MULTIPLE SCLEROSIS TREATMENT 14-Sep-2006
- BIONOMICS NOW NEWSLETTER 247 kb
29-Aug-2006 BIONOMICS' 2005/2006 PRELIMINARY FINAL REPORT 22-Aug-2006
- RAPID PIPELINE ADVANCE - INVESTOR UPDATE 465 kb
03-Aug-2006 CLARIFICATION OF MEDIA ARTICLE 03-Jul-2006
- BIONOMICS ANNOUNCES BOARD CHANGES 27 kb
30-Jun-2006 - OPEN BRIEFING - MD ON UPDATE AND PROGRESS 104 kb
20-Jun-2006 - DIRECTORS RESIGNATION 27 kb
16-Jun-2006 BIONOMICS LICENSEE LABCORP® LAUNCHES GENETIC TEST FOR EPILEPSY 08-Jun-2006
- THE NEW BIONOMICS - JUNE 2006 UPDATE PRESENTATION 1002 kb
05-Jun-2006 - Intersuisse Investment Research Report 464 kb
02-May-2006 AUDIO BROADCAST - UPDATE ON BIONOMICS LIMITED 28-Apr-2006
BIONOMICS NOMINATES CANCER DRUG CANDIDATE 21-Apr-2006
- DRUG CANDIDATE PRESENTATION 1211 kb
21-Apr-2006 BIONOMICS CANCER GENE PATENTS GRANTED 13-Apr-2006
BIONOMICS GRANTED EPILEPSY GENE PATENT 11-Apr-2006
BIONOMICS RECEIVES $3.7 MILLION GRANT FOR CANCER DRUG PROGRAM 05-Apr-2006
- Bionomics' 2005/2006 Half Year Financial Results 210 kb
14-Mar-2006 GENMAB LICENSES ANGIOGENESIS TARGETS FROM BIONOMICS 14-Feb-2006
- Corporatefile Open Breifing. MD on Strategy & Outllook 123 kb
08-Nov-2005 BIONOMICS LICENSES TWO EPILEPSY DIAGNOSTICS TO LABORATORY CORPORATION OF AMERICA 03-Nov-2005
- Bionomics 2005 AGM Presentation 658 kb
03-Nov-2005 BIONOMICS GRANTED PATENT FOR ANTI-CANCER COMPOUNDS 01-Nov-2005
BIONOMICS APPOINTS FULL-TIME CFO 06-Oct-2005
BIONOMICS RECEIVES US ALLOWANCE OF EPILEPSY GENE PATENT 02-Sep-2005
- Southern Cross Equities DNA, Devices & Dealers Presentation 196 kb
02-Sep-2005 - Corporate File Open Briefing - MD on Business Update. 108 kb
02-Sep-2005 BIONOMICS 2004/2005 RESULTS 19-Aug-2005
- Shareholder Newsletter 1103 kb
18-Jul-2005 BIONOMICS’ COMPLETES ILIAD ACQUISITION 01-Jul-2005
- EGM 2005 Presentation 168 kb
27-Jun-2005 BIONOMICS’ SHAREHOLDERS ENDORSE ILIAD ACQUISITION AND CAPITAL RAISING 27-Jun-2005
BIONOMICS PRESENTS NEW DATA ON BNO69 CANCER TARGET AT BIO2005 CONFERENCE 22-Jun-2005
- Bioshares Extract 27 kb
16-Jun-2005 CLINICAL STUDY CONFIRMS VALUE OF BIONOMICS’ CHILDHOOD EPILEPSY TEST 16-Jun-2005
- CORPORATEFILE OPEN BRIEFING. MD ON ILIAD ACQUISITION AND CAPITAL RAISING. 111 kb
26-May-2005 - BIONOMICS' ACQUISITION OF ILIAD CHEMICALS 128 kb
25-May-2005 GRANT OF DRUG DISCOVERY TARGET PATENT 12-May-2005
BIONOMICS FILES FURTHER PATENTS FOR BNO69 CANCER TARGET 10-May-2005
BIONOMICS AWARDED GRANT EXTENSION FOR NEURO DRUG DEVELOPMENT 05-May-2005
NEUROFIT ACQUISITION COMPLETED 02-Mar-2005
- corporatefile Open Briefing. Bionomics MD on Business Update & Strategy 126 kb
14-Feb-2005 DECEMBER QUARTER CASH FLOW BOOSTED BY COMMERCIALISATION INCOME 28-Jan-2005
GRANT OF ION CHANNEL PATENT 23-Dec-2004
Bionomics’ Acquisition of Neurofit - FAQ 17-Dec-2004
BIONOMICS ACQUIRES EUROPEAN CNS BUSINESS 17-Dec-2004
START GRANT EXTENSION FOR BIONOMICS’ BREAST CANCER WORK 15-Dec-2004
BIONOMICS COMMERCIALISATION GAINING MOMENTUM 11-Nov-2004
BIONOMICS AND GTG ANNOUNCE STRATEGIC ALLIANCE TO JOINTLY COMMERCIALISE NEW GENETIC TESTS FOR EPILEPSY 08-Nov-2004
BIONOMICS' GENE-SILENCING MOLECULES INHIBIT TUMOUR GROWTH IN BREAST CANCER MODEL 08-Nov-2004
BIONOMICS AWARDED GRANTS FOR ANTIBODY RESEARCH 04-Nov-2004
BIONOMICS CASH FLOW REPORT FOR THE QUARTER ENDED 30 SEPTEMBER 2004 26-Oct-2004
BIONOMICS APPOINTS NEW CHAIRMAN AND EXTENDS CEO CONTRACT 18-Oct-2004
BIONOMICS LICENSES EPILEPSY TEST 27-Sep-2004
BIONOMICS STRENGTHENS UNITED STATES PRESENCE 20-Sep-2004
Bionomics' 2003/2004 Financial Results 19-Aug-2004
- ASX Preliminary Final Report - 30 June 2004 723 kb
19-Aug-2004 BIONOMICS BNO69 ANGIOGENESIS GENE DISCOVERY PUBLISHED IN EMINENT JOURNAL 10-Aug-2004
- LOUISIANA STATE UNIVERSITY AND BIONOMICS SIGN CANCER GENE THERAPY AGREEMENT 88 kb
30-Jul-2004 BIONOMICS CASH FLOW REPORT FOR THE QUARTER ENDED 30 JUNE 2004 21-Jul-2004
BIONOMICS AND UNIVERSITY OF WISCONSIN-MADISON COLLABORATE ON EPILEPSY RESEARCH 07-Jul-2004
CHAIRMAN INTENDS TO RETIRE AFTER 6 YEARS IN THE ROLE 06-Jul-2004
BIONOMICS ION CHANNEL PATENT APPLICATION ACCEPTED IN NEW ZEALAND 05-Jul-2004
BIONOMICS' DATA ON PROPRIETARY DRUG TARGET PRESENTED AT US BIOTECHNOLOGY SYMPOSIUM 24-Jun-2004
BIONOMICS STRENGTHENS LINKS WITH WEHI 22-Jun-2004
BIONOMICS REPORTS PROGRESS IN DEVELOPMENT OF GENE TEST FOR EPILEPSY 21-Jun-2004
DRUG DISCOVERY FOCUS FOR SAB AND STAFF AT BIONOMICS 27-May-2004
- BIONOMICS' SHAREHOLDER NEWSLETTER 88 kb
21-May-2004 - PUBLICATION OF EPILEPSY RESEARCH 63 kb
13-May-2004 PERKINELMER AND BIONOMICS ANNOUNCE DRUG DISCOVERY COLLABORATION 10-May-2004
BIONOMICS CASH FLOW FOR THE QUARTER ENDED 31 MARCH 2004 22-Apr-2004
BIONOMICS EGM RESOUNDINGLY SUPPORTS CAPITAL RAISING 31-Mar-2004
BIONOMICS EXPANDS NETWORK OF DRUG DISCOVERY COLLABORATORS WITH SOUTHERN CROSS UNIVERSITY 30-Mar-2004
BIONOMICS PROGRESSES CANCER GENE PORTFOLIO 26-Mar-2004
EPILEPSY CLINICAL STUDY CONFIRMS BASIS OF EPILEPSY DIAGNOSTIC TEST 22-Mar-2004
BIONOMICS CONFIRMS PROSPECT OF DIAGNOSTIC TEST FOR CHILDHOOD EPILEPSY 10-Mar-2004
BIONOMICS ANTI CANCER IP ADVANCES INTO DRUG DISCOVERY 03-Mar-2004
BIONOMICS’ SHAREHOLDERS UNDERWRITTEN ENTITLEMENTS ISSUE 27-Feb-2004
BIONOMICS AND WALTER AND ELIZA HALL INSTITUTE DRUG DISCOVERY COLLABORATION 25-Feb-2004
BIONOMICS’ $6 MILLION FUNDING TO ACCELERATE DRUG DISCOVERY 23-Feb-2004
- Bionomics' Shareholder Newsletter 102 kb
30-Jan-2004 BIONOMICS CASH FLOW FOR THE QUARTER ENDED 31 DECEMBER 2003 20-Jan-2004
KEY EPILEPSY PATENT APPLICATION MOVES FORWARD 08-Jan-2004
FURTHER ADVANCE IN BIONOMICS EPILEPSY PROGRAM 02-Dec-2003
BIONOMICS EPILEPSY RESEARCH TO BE FUNDED BY NIH 25-Nov-2003
PROGRESSION OF BIONOMICS' EPILEPSY PATENT APPLICATION 06-Nov-2003
BIONOMICS CASH FLOW FOR THE QUARTER ENDED 30 SEPTEMBER 2003 20-Oct-2003
BIONOMICS FILES PATENT ON BREAST CANCER DIAGNOSTIC 15-Oct-2003
NEW EPILEPSY DIAGNOSTIC PATENT 14-Oct-2003
BIONOMICS EPILEPSY RESEARCH PUBLISHED IN NEUROLOGY 30-Sep-2003
BIONOMICS IDENTIFIES NEW EPILEPSY GENE 11-Sep-2003
FURTHER PROGRESS IN BUILDING BREAST CANCER IP 11-Aug-2003
BREAST CANCER PATENT APPLICATION ENTERS EXAMINATION 04-Aug-2003
BIONOMICS APPOINTS CHIEF FINANCIAL OFFICER 01-Aug-2003
BIONOMICS ENTERS INTO FINANCING ARRANGEMENT WITH AN AFFILIATE OF THE BANK OF NEW YORK 14-Jul-2003
BIONOMICS PRESENTS AT BIO 2003, WASHINGTON DC 23-Jun-2003
BIONOMICS APPOINTS US EXPERT TO LEAD DRUG DISCOVERY 04-Jun-2003
BIONOMICS PRESENTS AT BIO EXPO JAPAN 2003 15-May-2003
- Appendix 4C 120 kb
24-Apr-2003 BIONOMICS INCREASES CASH RESERVES 24-Apr-2003
FURTHER PUBLICATION OF KEY EPILEPSY GENE DISCOVERIES 07-Apr-2003
- EXTENSION OF OFFER CLOSE DATE FOR BIONOMCS' SHARE PURCHASE PLAN 38 kb
20-Mar-2003 BIONOMICS HALF YEAR RESULTS 12-Mar-2003
BIONOMICS PRESENTS AT BIO CEO & INVESTOR CONFERENCE 27-Feb-2003
BIONOMICS ESTABLISHES NEUROSCIENCE RESEARCH COLLABORATION WITH HOWARD FLOREY INSTITUTE 25-Feb-2003
- EXCITING OFFER FOR SHAREHOLDERS - SHARE PURCHASE PLAN 91 kb
21-Feb-2003 BIONOMICS RECEIVES $2.9M FOR CNS DRUG DISCOVERY PROGRAM 19-Feb-2003
BIONOMICS BOOSTS BOARD LINE-UP WITH US APPOINTMENT 10-Feb-2003
BIONOMICS AND JJR COLLABORATION CONCLUDED 07-Feb-2003
BIONOMICS DEVELOPS MODEL TO ACCELERATE ANGIOGENESIS DRUG DISCOVERY 29-Jan-2003
BIONOMICS EXPANDS SCOPE OF EPILEPSY GENE DISCOVERIES 23-Jan-2003
Bionomics Reinforces its Stamp of Authority on Epilepsy Field 09-Dec-2002
EPILEPSY PAPER PUBLICATION 03-Dec-2002
- RESULTS OF AGM 43 kb
07-Nov-2002 BIONOMICS BROADENS COMMERCIAL OPPORTUNITIES WITH NEW DRUG DISCOVERY PLATFORM 07-Nov-2002
- AGM ADDRESS 107 kb
07-Nov-2002 - AGM PRESENTATION 293 kb
07-Nov-2002 Bionomics US Listing - ADRs Launched 02-Oct-2002
Bionomics and Nanogen in Epilepsy Diagnostic Deal 01-Oct-2002
Bionomics advances over 100 novel genes to international patent stage in angiogenesis program 19-Sep-2002
PARTNERSHIPS, PATENTS AND PEOPLE DRIVE BIONOMICS’ GROWTH IN SHAREHOLDER VALUE 09-Sep-2002
BIONOMICS BREAKTHROUGH - WORLD’S FIRST ANIMAL MODEL OF INHERITED HUMAN EPILEPSY 09-Sep-2002
BIONOMICS TRIPLES PORTFOLIO OF EPILEPSY GENE DISCOVERIES 08-Jul-2002
BIONOMICS AND GENMAB PROGRESS COLLABORATION WITH THIRD TARGET 29-May-2002
Bionomics expands patent portfolio with new epilepsy gene discoveries 14-May-2002
Bionomics signs Collaboration Agreement with Johnson And Johnson Research Pty Limited 09-May-2002
SOUTH AUSTRALIAN’S KEY ROLE ON NATIONAL BIOTECH COUNCIL 25-Mar-2002
PARTNERSHIPS MOVE BIONOMICS CLOSER TO CLINIC 14-Mar-2002
BIONOMICS AND GENMAB TO CO-DEVELOP HUMAN ANTIBODIES FOR ANGIOGENESIS TARGETS 12-Mar-2002
HYBRIGEN INC. AND BIONOMICS LIMITED EXPAND DRUG TARGET DISCOVERY ALLIANCE 30-Jan-2002
BIONOMICS ANNOUNCES FURTHER EXPANSION TO ITS SCIENTIFIC BASE 17-Dec-2001
BIONOMICS SECURES GLOBAL COMMERCIALISATION SKILLS 10-Dec-2001
Bionomics Secures Major Breast Cancer Grant - Substantial Boost to R&D 04-Dec-2001
Bionomics Appoints Eminent Cancer Researcher to Scientific Advisory Board 08-Nov-2001
GENE EXPERT APPOINTED AS BIONOMICS EXPANDS 05-Nov-2001
ANGIOGENESIS PATENT FILED ON NOVEL GENES 03-Oct-2001
HYBRIGEN INC AND BIONOMICS LIMITED ANNOUNCE DRUG TARGET DISCOVERY ALLIANCE 20-Sep-2001
BIONOMICS IP HEADED FOR COMMERCIALISATION 11-Sep-2001
BIONOMICS GENE IMPLICATED IN 50% OF BREAST CANCERS 03-Sep-2001
UNDERWRITING OF OPTIONS CONVERSION 27-Aug-2001
FEDERAL GOVERNMENT GRANT AWARDED TO BIONOMICS 17-Aug-2001
WORLD LEADING BIOTECH EXECUTIVE JOINS BIONOMICS BOARD 07-Aug-2001
BIONOMICS AND OZGENE DEAL TO BOOST BREAST CANCER RESEARCH 05-Jun-2001
BIONOMICS TO MAKE $4.04 MILLION PLACEMENT 31-May-2001
BIONOMICS SECURES WORLD-WIDE RIGHTS TO ANGIOGENESIS GENES 24-May-2001
GENETIC ABNORMALITY LINKED TO EPILEPSY 14-May-2001
EMINENT CANCER RESEARCHER APPOINTED CHIEF SCIENTIST 03-May-2001
Building Talks Highlight of Half Year Results 14-Mar-2001
BIONOMICS MOVES ON 100 GENES 14-Feb-2001
GENE PATENT APPLICATION LINKED TO CANCER CELL ACTIVITY 31-Jan-2001
SCIENTIFIC EXPERTISE RECOGNISED 29-Jan-2001
TOP SCIENTIST HONORED AS AUSTRALIAN ACHIEVER 25-Jan-2001
BIONOMICS IDENTIFIES A GENE ASSOCIATED WITH BREAST CANCER 01-Jan-2001
BIONOMICS CELEBRATES ONE YEAR ANNIVERSARY OF LISTING 22-Dec-2000
BIONOMICS PATENTS THIRD GENE FROM BREAST CANCER PROJECT 15-Dec-2000
BIONOMICS AWARDED R&D START GRANT TO SUPPORT EPILEPSY GENE DISCOVERY 13-Dec-2000
WORLD BIOTECHNOLOGY LEADERS IN ADELAIDE 27-Nov-2000
BIONOMICS TO MAKE $5 MILLION PLACEMENT 28-Jul-2000
BROAD EPILEPSY GENE PATENT FILED BY BIONOMICS 18-Jul-2000
RELEASE OF HUMAN GENOME PROJECT DATA WILL ADVANCE BIONOMICS GENE DISCOVERY PROGRAMS 26-Jun-2000
EPILEPSY GENE DISCOVERIES BY BIONOMICS 21-Jun-2000
APPOINTMENT OF PROFESSOR SAM BERKOVIC AS A MEMBER OF THE BIONOMICS SCIENTIFIC ADVISORY BOARD 08-Jun-2000
BIONOMICS APPOINTS CHIEF EXECUTIVE OFFICER 18-May-2000
GENE TEAM TO LIST THROUGH $7 MILLION FLOAT 02-Dec-1999
- BIONOMICS TO CONDUCT BNC105 PHASE II TRIAL FOR MESOTHELIOMA TREATMENT 150 kb
07-Sep-2010
